The Billion-Dollar Molecule
Autor Barry Werthen Limba Engleză Paperback – mar 1995
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Preț: 118.91 lei
Puncte Express: 178
Carte disponibilă
Livrare economică 17-31 octombrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit de la 400.00 lei Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780671510572
ISBN-10: 0671510576
Pagini: 464
Dimensiuni: 140 x 211 x 34 mm
Greutate: 0.41 kg
Ediția:Revised edition
Editura: Simon&Schuster
ISBN-10: 0671510576
Pagini: 464
Dimensiuni: 140 x 211 x 34 mm
Greutate: 0.41 kg
Ediția:Revised edition
Editura: Simon&Schuster
Notă biografică
Barry Werth is an award-winning journalist and the author of eight books. His landmark first book, The Billion-Dollar Molecule, recounts the founding and early struggles of a startup pharmaceutical company, Vertex, in its quest for the perfect drug. His sequel, The Antidote, continues the story of Vertex as it emerges as a leader in delivering breakthrough medicines. The Age of Cures, the final book in his trilogy, introduces readers to the founding visionaries of the pharmaceutical revolution. Werth’s articles have appeared in The New Yorker, The New York Times Magazine, and GQ, among other publications. He has taught journalism and nonfiction writing at Smith College, Mount Holyoke College, and Boston University. He lives in Northampton, Massachusetts.
Descriere
This inside account of Vertex, a start-up pharmaceutical company, conveys the exciting drama being played out in the pioneering and enormously profitable field of drug research. Vertex is dedicated to designing--atom by atom--a new life-saving immunosuppressant drug that has major implications for HIV research.